Research and Markets: SWOT Analysis of Chugai Pharmaceutical Co., Ltd. - Examine their Strengths, Weaknesses, Opportunities and Threats

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/5019b5/chugai_pharmaceuti) has
announced the addition of the "Chugai Pharmaceutical Co., Ltd. - SWOT Analysis"
company profile to their offering.

The Chugai Pharmaceutical Co., Ltd. - SWOT Analysis company profile is the
essential source for top-level company data and information. Chugai
Pharmaceutical Co., Ltd. - SWOT Analysis examines the company's key business
structure and operations, history and products, and provides summary analysis of
its key revenue lines and strategy.

Chugai Pharmaceutical (Chugai), a subsidiary of the Roche Group, is engaged in
biopharmaceutical research and development. It produces antibody drugs, focused
in the three areas, oncology, renal diseases and bone and joint diseases. The
company primarily operates in Europe, Americas and Asia Pacific. It is
headquartered in Tokyo, Japan and employed 6,383 people as of December 2008. The
company recorded revenues of JPY326,938 million (approximately $3,171.3
million-) during the financial year (FY) ended December 2008, a decrease of 5.2%
over FY2007. The decrease was mainly due to the significant drop in Epogin sales
when compared with that of previous year. The operating profit of the company
was JPY51,563 million (approximately $500.2 million-) during FY2008, a decrease
of 22.7% over FY2007. The net profit was JPY39,265 million (approximately $380.9
million-) in FY2008, a decrease of 2% over FY2007. -Calculated using the
constant conversion rate of JPY1 = $0.0097 for the year ended December 2008.

Scope of the Report

* Provides all the crucial information on Chugai Pharmaceutical Co., Ltd.
required for business and competitor intelligence needs
* Contains a study of the major internal and external factors affecting Chugai
Pharmaceutical Co., Ltd. in the form of a SWOT analysis as well as a breakdown
and examination of leading product revenue streams of Chugai Pharmaceutical Co.,
Ltd.
* Data is supplemented with details on Chugai Pharmaceutical Co., Ltd. history,
key executives, business description, locations and subsidiaries as well as a
list of products and services and the latest available statement from Chugai
Pharmaceutical Co., Ltd.

Reasons to Purchase

* Support sales activities by understanding your customers' businesses better
* Qualify prospective partners and suppliers
* Keep fully up to date on your competitors' business structure, strategy and
prospects
* Obtain the most up to date company information available

For more information visit
http://www.researchandmarkets.com/research/5019b5/chugai_pharmaceuti

Source: Datamonitor

Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716

Copyright Business Wire 2009